"Mercy Health - Cancer Center in Elyria, Ohio is one of Mercy Health's many Cancer Care and Oncology locations serving communities across Ohio and Kentucky."

During the past decade, Mercy Cancer Center-Elyria conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 57 clinical trials were completed, i.e. on average, 107.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 39 clinical trials were completed. i.e. 557.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Cancer Center-Elyria" #1 sponsor was "National Cancer Institute (NCI)" with 49 trials, followed by "SWOG Cancer Research Network" with 20 trials sponsored, "NRG Oncology" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Cancer Center-Elyria" #1 collaborator was "National Cancer Institute (NCI)" with 53 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Cancer Center-Elyria" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Recurrent Breast Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IV Breast Cancer AJCC v6 and v7" (6 trials) and "Invasive Breast Carcinoma" (5 trials). Many other conditions were trialed in "Mercy Cancer Center-Elyria" in a lesser frequency.

Most popular intervention types in "Mercy Cancer Center-Elyria" are "Drug" (88 trials), "Other" (72 trials), "Biological" (45 trials), "Radiation" (31 trials) and "Procedure" (15 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (54 trials), "Quality-of-Life Assessment" (20 trials), "Cisplatin" (14 trials), "Paclitaxel" (14 trials) and "Carboplatin" (12 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Cancer Center-Elyria" are 86 trials for "All" genders, 9 trials for "Male" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Mercy Cancer Center-Elyria". undefined are not yet recruiting, 16 are recruiting, 55 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Mercy Cancer Center-Elyria, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Cancer Center-Elyria, 3 "Phase 1" clinical trials were conducted, 50 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".